Biota Pharmaceuticals CEO Andrei Floroiu's 2022 pay jumps 49% to $3.6M
Biota Pharmaceuticals reports 2022 executive compensation
By ExecPay News
Published: April 28, 2023
Biota Pharmaceuticals reported fiscal year 2022 executive compensation information on April 28, 2023.
In 2022, three executives at Biota Pharmaceuticals received on average a compensation package of $2.5M, a 24% increase compared to previous year.
Average pay of disclosed executives at Biota Pharmaceuticals
Andrei Floroiu, Chief Executive Officer, received $3.6M in total, which increased by 49% compared to 2021. 69% of Floroiu's compensation, or $2.5M, was in option awards. Floroiu also received $133K in non-equity incentive plan, $533K in salary, $433K in stock awards, as well as $9.4K in other compensation.
For fiscal year 2022, the median employee pay was $163,906 at Biota Pharmaceuticals. Therefore, the ratio of Andrei Floroiu's pay to the median employee pay was 22 to one.
James Cummings, Chief Medical Officer, received a compensation package of $1.9M, which decreased by 19% compared to previous year. 61% of the compensation package, or $1.2M, was in option awards.
Sean N. Tucker, Chief Scientific Officer, earned $1.9M in 2022, a 59% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 28, 2023.